NCT01286558 - Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg) | Biotech Hunter

Enrollment

225

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

September 30, 2011

Conditions

Hypertension

Interventions

DRUG

40 mg telmisartan

once daily

DRUG

5 mg amlodipine

once daily

DRUG

5 mg amlodipine

once daily

DRUG

80 mg telmisartan

once daily

Trial Locations (8)

1235.37.01 Boehringer Ingelheim Investigational Site, Chuo-ku,Tokyo

1235.37.07 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

1235.37.08 Boehringer Ingelheim Investigational Site, Itoshima, Fukuoka

1235.37.02 Boehringer Ingelheim Investigational Site, Katsushika-ku, Tokyo

1235.37.05 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1235.37.03 Boehringer Ingelheim Investigational Site, Ota-ku, Tokyo

1235.37.06 Boehringer Ingelheim Investigational Site, Suita, Osaka

1235.37.04 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa